malignant salivary gland tumors

Upload: fabio-vega-braga

Post on 29-May-2018

233 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 Malignant Salivary Gland Tumors

    1/21

    MALIGNANT SALIVARY

    GLAND TUMORS

    MALIGNANT SALIVARY

    GLAND TUMORS

    MMucoepidermoid carcinomaucoepidermoid carcinomaAAdenoid cystic carcinomadenoid cystic carcinoma

    AAcinic cell carcinomacinic cell carcinoma

  • 8/8/2019 Malignant Salivary Gland Tumors

    2/21

  • 8/8/2019 Malignant Salivary Gland Tumors

    3/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

    CLINIC AL FEATURES:CLINIC AL FEATURES:A dulthood tumor A dulthood tumor Significant female predilectionSignificant female predilection

    S ITE:S ITE:50% MEC occur in the parotid gland (arising in50% MEC occur in the parotid gland (arising insuperficial lobe)superficial lobe)

    20%

    occur on the palate20%

    occur on the palateRest of the lesions arising from the minor salivaryRest of the lesions arising from the minor salivaryglands with the buccal mucosa, lips, tongue and retroglands with the buccal mucosa, lips, tongue and retromolar areas to be the favored sites.molar areas to be the favored sites.

    C/F.. Cont..dC/F.. Cont..d

  • 8/8/2019 Malignant Salivary Gland Tumors

    4/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

    T he tumor may be movable, which is anT he tumor may be movable, which is anuncommon feature for a malignant tumor.uncommon feature for a malignant tumor.High grade lesions are often fixed to theHigh grade lesions are often fixed to theadjacent tissues.adjacent tissues.T heir size is 1T heir size is 1- -4 cm when diagnosed.4 cm when diagnosed.T

    here may be facial weakness due to VIIT

    here may be facial weakness due to VIInerve involvement.nerve involvement.

  • 8/8/2019 Malignant Salivary Gland Tumors

    5/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

  • 8/8/2019 Malignant Salivary Gland Tumors

    6/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

    H ISTOPAT H OL OGY:H ISTOPAT H OL OGY:T

    hey have three dominant cell typesT

    hey have three dominant cell typesMucinous, epidermoid and intermediateMucinous, epidermoid and intermediateT heir cells are arranged in the nests andT heir cells are arranged in the nests anddiffuse sheets that may surround cysticdiffuse sheets that may surround cystic

    spacesspacesT here is no capsule, but the edge of theT here is no capsule, but the edge of thetumor is welltumor is well- -demarcateddemarcated

  • 8/8/2019 Malignant Salivary Gland Tumors

    7/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

    T here may be focal areas of malignant cellsT here may be focal areas of malignant cellsinfiltrated into the normal salivary tissueinfiltrated into the normal salivary tissueT umors predominant mucous cells and moreT umors predominant mucous cells and morecystic spaces are classified as low gradecystic spaces are classified as low grade(with limited metastatic potential)(with limited metastatic potential)T

    hose with solid sheets and fewer mucousT

    hose with solid sheets and fewer mucoussecreting cells and high proportion of secreting cells and high proportion of stratified squamous epithelium are classifiedstratified squamous epithelium are classifiedas high grade tumorsas high grade tumors

  • 8/8/2019 Malignant Salivary Gland Tumors

    8/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

  • 8/8/2019 Malignant Salivary Gland Tumors

    9/21

    Mucoepidermoid CarcinomaLOW GRADE / HIGH GRADE

    Mucoepidermoid CarcinomaLOW GRADE / HIGH GRADE

  • 8/8/2019 Malignant Salivary Gland Tumors

    10/21

    Mucoepidermoid CarcinomaMucoepidermoid Carcinoma

    TREATME N T/PROG N OS IS:TREATME N T/PROG N OS IS:L ow grade tumors follow a benign courseL ow grade tumors follow a benign coursewhereas high grade show distant metastasiswhereas high grade show distant metastasisto the regional lymph nodes as well ( cervicalto the regional lymph nodes as well ( cervicallymph nodes)lymph nodes)T reatment of primary malignancy is managedT reatment of primary malignancy is managedwith surgery followed by radiotherapy to thewith surgery followed by radiotherapy to theprimary site.primary site.Prognosis depends on the histological gradePrognosis depends on the histological gradeof the malignancy.of the malignancy.

  • 8/8/2019 Malignant Salivary Gland Tumors

    11/21

    ADENOID CYSTICCARCINOMAADENOID CYSTICCARCINOMA

  • 8/8/2019 Malignant Salivary Gland Tumors

    12/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMA

    It is a malignant salivary gland tumor It is a malignant salivary gland tumor composed of cuboidal cells in a solidcomposed of cuboidal cells in a solidcribriform tubular patterncribriform tubular patternA CC is one of the most deceptive and A CC is one of the most deceptive andfrustrating tumor of the head and neck regionfrustrating tumor of the head and neck region

    ORIG

    IO

    NOR

    IG

    IO

    N :

    : A CC arises from intercalated duct reserve A CC arises from intercalated duct reserve

    cells or the terminal tube complexcells or the terminal tube complex

  • 8/8/2019 Malignant Salivary Gland Tumors

    13/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMACLINIC AL FEATURES:CLINIC AL FEATURES:

    Peak incidence is in sixth decade of life withPeak incidence is in sixth decade of life withslight female predilectionslight female predilection5050 --70% cases reported are in the minor 70% cases reported are in the minor salivary glands, the major glands that aresalivary glands, the major glands that areaffected are the parotid glandsaffected are the parotid glandsIn major salivary glands, the clinicalIn major salivary glands, the clinicalappearance is that of a unilocular mass,appearance is that of a unilocular mass,which is firm on palpationwhich is firm on palpationT here might be some pain and tendernessT here might be some pain and tenderness

  • 8/8/2019 Malignant Salivary Gland Tumors

    14/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMAT he lesion has a slow growth rate.T he lesion has a slow growth rate.

    Facial nerve paralysis or weakness maybeFacial nerve paralysis or weakness maybethe initial symptomthe initial symptomBone invasion occurs frequently. T here areBone invasion occurs frequently. T here areno radiographic changes initially as there isno radiographic changes initially as there is

    infiltration through the marrow spacesinfiltration through the marrow spacesMetastasis is often seen in lungsMetastasis is often seen in lungsT he tumor has tendency to invade theT he tumor has tendency to invade theperinural spacesperinural spaces

  • 8/8/2019 Malignant Salivary Gland Tumors

    15/21

  • 8/8/2019 Malignant Salivary Gland Tumors

    16/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMAT here are no mitotic figuresT here are no mitotic figuresT

    here is formation of pseudocystic spacesT

    here is formation of pseudocystic spacesthat contain variety of acellular substancesthat contain variety of acellular substancesMyoepithelial cells may represent a minor Myoepithelial cells may represent a minor part of the cellular componentpart of the cellular component

  • 8/8/2019 Malignant Salivary Gland Tumors

    17/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMA

  • 8/8/2019 Malignant Salivary Gland Tumors

    18/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMA

  • 8/8/2019 Malignant Salivary Gland Tumors

    19/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMA

  • 8/8/2019 Malignant Salivary Gland Tumors

    20/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMA

  • 8/8/2019 Malignant Salivary Gland Tumors

    21/21

    ADENOID CYSTIC

    CARCINOMA

    ADENOID CYSTIC

    CARCINOMATREATME N T/PROG N OS IS:TREATME N T/PROG N OS IS:

    Primary lesion always requires surgical innervation inPrimary lesion always requires surgical innervation in

    the parotid gland with resection in the form of the parotid gland with resection in the form of superficial parotidectomy or deep lobulectomysuperficial parotidectomy or deep lobulectomyPost surgical radiotherapy has shown promisingPost surgical radiotherapy has shown promisingresultsresultsMultiple agent chemotherapy has shown someMultiple agent chemotherapy has shown somepromise in the management of the patients withpromise in the management of the patients withmetastatic diseasemetastatic disease5 years survival rate is approximately 7 0%5 years survival rate is approximately 7 0%A fter 1 5 years, the rate drops to 1 0% only. A fter 1 5 years, the rate drops to 1 0% only.